Sign up to save your podcasts
Or
Share Pharma and Biotech Daily: FDA Delays Decision on Donanemab, Biden Addresses Drug Prices, Brukinsa Approval, ALS Drug Uncertainty, and Industry Layoffs.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pharma and Biotech Daily: FDA Delays Decision on Donanemab, Biden Addresses Drug Prices, Brukinsa Approval, ALS Drug Uncertainty, and Industry Layoffs.
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. The FDA has delayed its decision on Eli Lilly's Alzheimer's drug, Donanemab, and will convene a committee to discuss the application. President Biden addressed drug prices in the State of the Union, calling for lower prescription drug prices. Additionally, Beigene's Brukinsa was approved for follicular lymphoma, and Amylyx's ALS drug faced uncertainty after a Phase III trial failure. Other news included BMS gaining FDA approval for Opdivo in first-line bladder cancer and Merck KGaA discontinuing a BTK inhibitor after a Phase III trial failure. The biopharma industry is experiencing layoffs, with companies like Sumitomo and Evonik cutting staff.
Support the Show.
View all episodes
By Pharma and BioTech News
3.5
1414 ratings
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. The FDA has delayed its decision on Eli Lilly's Alzheimer's drug, Donanemab, and will convene a committee to discuss the application. President Biden addressed drug prices in the State of the Union, calling for lower prescription drug prices. Additionally, Beigene's Brukinsa was approved for follicular lymphoma, and Amylyx's ALS drug faced uncertainty after a Phase III trial failure. Other news included BMS gaining FDA approval for Opdivo in first-line bladder cancer and Merck KGaA discontinuing a BTK inhibitor after a Phase III trial failure. The biopharma industry is experiencing layoffs, with companies like Sumitomo and Evonik cutting staff.
Support the Show.
More shows like Pharma and BioTech Daily
View all
WSJ Your Money Briefing
1,721 Listeners
WSJ What’s News
4,356 Listeners
The McKinsey Podcast
391 Listeners
WSJ Tech News Briefing
1,639 Listeners
HBR IdeaCast
176 Listeners
The Long Run with Luke Timmerman
123 Listeners
The Readout Loud
324 Listeners
Becker’s Healthcare Podcast
190 Listeners
Morning Brew Daily
3,002 Listeners
Inside Global Pharma
10 Listeners
Business Of Biotech
86 Listeners
BioCentury This Week
34 Listeners
Biotech Hangout
19 Listeners
The Top Line
14 Listeners
The AI Podcast
6 Listeners